Abiopharma

🔍 Thauberger Matthew (Executive)

Company: Super Micro Computer, Inc. (SMCI)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 2,250 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,632.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,145 shares of Common Stock at $38.28 per share (Direct)
  Date: 2026-08-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,487.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,250 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of SMCI common stock.
• F2: Represents shares of SMCI common stock that have been withheld by SMCI to satisfy tax withholding and remittance obligations in connection with the net settlement of vested restricted stock units and not a market transaction. Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-3(e) promulgated under the Act.
• F3: Subject to the Reporting Person's continued service to SMCI, the restricted stock units vested in two equal tranches on August 17, 2026 and February 17, 2027. Vested units were settled in shares of SMCI common stock.